Dilution profile // every instrument, one screen, from SEC filings

Proto Labs Inc (PRLB)

CIK 1443669 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGHS-3ASR on file 2021-02-16
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
LOWwarrants = 0% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW-8% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-10-292026-07-28

Latest: 23.9M shares as of Jul 28, 2026 (10-Q).

Cash runway

Self-funding

profitable · generates cash

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 105,000 underlying shares, as reported Dec 31, 2010 (10-K).

Balance-sheet fair value of warrants: $0 as of Dec 31, 2013.

Rough fully diluted estimate: 24.0M = 23.9M O/S + 105,000 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Jul 31, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding23.9MJul 28, 2026
+ Warrants (aggregate, as tagged) (if exercised)105,000Dec 31, 2010
Fully diluted estimate24.0M+0.4% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

REGISTEREDFeb 16, 2021Automatic shelf registration — effective immediately (large filers)S-3ASR
EXECUTEDJan 25, 2021Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDJan 19, 2021Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDNov 16, 2012Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B1
EFFECTIVENov 15, 2012SEC declared a registration effective — selling can beginEFFECT
REGISTEREDNov 13, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDOct 31, 2012S-1 registration — capacity to sell shares, not a sale yetS-1
EXECUTEDFeb 27, 2012Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4
EFFECTIVEFeb 23, 2012SEC declared a registration effective — selling can beginEFFECT
REGISTEREDFeb 21, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDFeb 13, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDFeb 1, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full PRLB workspace